A policy analysis of major decisions relating to Creutzfeldt–Jakob disease and the blood supply

K Wilson, PC Hébert, A Laupacis, C Dornan, M Ricketts… - CMAJ, 2001 - Can Med Assoc
CREUTZFELDT–JAKOB DISEASE (CJD) IS THE FIRST major challenge that the blood
system has faced since the completion of the Krever inquiry in 1997. We report the results of …

Variant Creutzfeldt‐Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies

PK Correll, MG Law, CR Seed, A Gust, M Buring… - Vox …, 2001 - Wiley Online Library
Background and Objectives In Australia, a policy of deferring donors who have lived in the
UK for longer than 6 months between 1980 and 1996 has been instituted to reduce the …

The application of the precautionary principle to the blood system: The Canadian blood system's vCJD donor deferral policy

K Wilson, M Wilson, PC Hébert, I Graham - Transfusion medicine reviews, 2003 - Elsevier
The precautionary principle is an influential concept that has been widely used in
international treaties and declarations involving the protection of the environment. The …

Variant Creutzfeldt–Jakob disease and the Canadian blood system after the tainted blood tragedy

K Wilson, I Graham, M Ricketts, C Dornan… - Social Science & …, 2007 - Elsevier
The transfusion transmission of hepatitis C and HIV to thousands of Canadian blood
recipients was one of this country's largest public health catastrophes. In response to this …

[PDF][PDF] New variant Creutzfeldt-Jakob disease and the blood supply: Is it time to face the music?

J Hoey, A Giulivi, AM Todkill - CMAJ, 1998 - Can Med Assoc
UK and will begin leukodepletion processing of donated blood. These decisions were taken
on the basis of evidence that the “hypothetical” risk that new variant Creutzfeldt–Jakob …

Creutzfeldt–Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study

PE Hewitt, CA Llewelyn, J Mackenzie, RG Will - Vox sanguinis, 2006 - Wiley Online Library
Background and Objectives This paper reports the results to 1 March 2006 of an ongoing UK
study, the Transfusion Medicine Epidemiological Review (TMER), by the National CJD …

Lack of evidence of transfusion transmission of Creutzfeldt‐Jakob disease in a US surveillance study

K Dorsey, S Zou, LB Schonberger, M Sullivan… - …, 2009 - Wiley Online Library
BACKGROUND: Since 2004, several reported transfusion transmissions of variant
Creutzfeldt‐Jakob disease (vCJD) in the United Kingdom have reawakened concerns about …

Geographic exposure risk of variant Creutzfeldt‐Jakob disease in US blood donors: a risk‐ranking model to evaluate alternative donor‐deferral policies

H Yang, Y Huang, L Gregori, DM Asher, T Bui… - …, 2017 - Wiley Online Library
BACKGROUND Variant Creutzfeldt‐Jakob disease (vCJD) has been transmitted by blood
transfusion (TTvCJD). The US Food and Drug Administration (FDA) recommends deferring …

The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt‐Jakob disease

K Wilson, MN Ricketts - Transfusion, 2004 - Wiley Online Library
The precautionary principle has emerged as an important new paradigm influencing
decision making in the blood system. The principle has influenced decision making in …

[HTML][HTML] Insights into the management of emerging infections: regulating variant Creutzfeldt-Jakob disease transfusion risk in the UK and the US

ML Ponte - PLoS medicine, 2006 - journals.plos.org
Background Variant Creutzfeldt-Jakob disease (vCJD) is a human prion disease caused by
infection with the agent of bovine spongiform encephalopathy. After the recognition of vCJD …